GlassScriptPhysician profile
Lacey Pflibsen
NPI 1750735718
$4,501.36
in general payments reported to CMS, 2019-2025
18 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $123 · 2021: $507 · 2022: $797 · 2023: $427 · 2024: $1,784 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.21 |
| Travel and Lodging | $1,089.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $960.66 | 2024 | |
| True North Surgical INC | $615.40 | 2024 | |
| Sientra, INC. | $605.79 | 2020-2022 | |
| Mentor Worldwide LLC | $558.74 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $279.73 | 2019-2022 | |
| Tela Bio, INC. | $256.42 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endo Pharmaceuticals INC. | $248.87 | 2022-2023 | Xiaflex |
| Stryker Corporation | $154.28 | 2021 | |
| Axogen | $146.74 | 2022-2023 | Avance Nerve Graft |
| Innovation Technologies INC | $133.79 | 2022 | |
| Acell, INC. | $125.10 | 2019 | |
| Kci USA, INC. | $85.27 | 2019 | |
| Checkpoint Surgical, INC | $76.72 | 2023 | Checkpoint Stimulators |
| Abbvie INC. | $75.25 | 2023 | |
| Zimmer Biomet Holdings, INC. | $67.85 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $48.99 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $36.01 | 2025 | Exparel |
| Skeletal Dynamics INC | $25.75 | 2023 | Geminus, Align, Implate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Pflibsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.